Also trades as: IPA.V (TSXV)
IPA NASDAQ
ImmunoPrecise Antibodies Ltd.
1W: -2.8%
1M: +8.9%
3M: -33.1%
1Y: +258.3%
3Y: -66.4%
5Y: -75.8%
$1.62
Last traded 2025-11-17 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$6M
-51.0% ▼
Capital Expenditures
$799K
+42.8% ▲
5Y CAGR: +6.8%
Free Cash Flow
-$7M
-27.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$7M
+250.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$7M | -$17M | -$27M | -$27M | -$30M |
| Depreciation & Amort. | $4M | $4M | $7M | $6M | $5M |
| Stock-Based Comp. | $3M | $3M | $2M | $2M | $445K |
| Change in Working Capital | -$1M | $582K | -$3M | $2M | $277K |
| Other Non-Cash Items | $1M | -$310K | $2M | $16M | $22M |
| Operating Cash Flow | -$600K | -$10M | -$20M | -$4M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$1M | -$1M | -$1M | -$799K |
| Acquisitions (Net) | -$1M | -$4M | -$592K | -$146K | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $80K | $121K | $0 |
| Other Investing | $0 | -$259K | $40K | -$141K | $0 |
| Investing Cash Flow | -$2M | -$5M | -$2M | -$2M | -$799K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$772K | -$962K | -$1M | -$1M | $3M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$5K | $0 | $0 | $0 |
| Financing Cash Flow | $43M | $3M | -$621K | $1M | $15M |
| Net Change in Cash | $39M | -$12M | -$22M | -$5M | $7M |
| Cash End of Period | $42M | $30M | $8M | $4M | $11M |
| Free Cash Flow | -$2M | -$11M | -$21M | -$6M | -$7M |